Patent · US Active

Method for treating hearing loss

US9144565B2 · kind B2 · utility

4Cited by

16References

24Claims

0Family size

Assignee

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · US

Inventors

Josef Miller · Ann Arbor, US
Glenn E. Green · Dexter, US
Colleen LePrell · Gainesville, US

Key dates

Filing date	Mar 15, 2013
Grant date	Sep 29, 2015
Priority date	—
Expiry date	Jun 16, 2033

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P31/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A method of treating hearing loss includes the step administering a composition to the mammal, wherein the composition consists essentially of a biologically effective amount of vitamin A, vitamin E, vitamin C, a vasodilator comprising magnesium, and, optionally, a withanolide, and/or resveratrol.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.